Recent research has shown them to be effective in reducing nausea in up to 80% of patients taking GLP1 medication and suffering from nausea as a side effect to their medication as early as first time use
Why Semaglutide Compound Stands Out Semaglutide Compound, branded as Subsema by Alliant LTC Pharmacy, embraces the potentials of GLP-1 receptor agonism with a state-of-the-art, water-free formulation designed for sublingual (under-the-tongue) administration
Composition CJC-1295 (Without DAC): 5 mg Ipamorelin: 5 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Comparative and combined pathway evaluation of GHRH analog + GHS agonist in in-vitro or ex-vivo models Assessment of assay development, including chromatographic separation of co-formulated peptides Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Documentation COA pending third-party verification in progress Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA (HPLC/LC-MS) with verification key Third-party verification link provided per lot (Janoshik) Lyophilized for transit stability
Researchers can request a COA with their order by directly contacting us, and well provide one so you can conduct your research with confidence and data reliability
Algarni MA, Stoessl AJ
Tailored Medication Protocol: Selecting the right GLP-1 medication, with precise dosing schedules adjusted for optimal results and minimal side effects
